Microarray patches: scratching the surface of vaccine delivery

Area of Science:

• Biotechnology
• Immunology
• Public Health

Background:

• Microneedle array patches (MAPs) are an emerging technology for vaccine delivery.
• MAPs present numerous advantages over conventional needle and syringe methods.
• Preclinical studies confirm MAPs' effectiveness in eliciting strong immune responses.

Purpose of the Study:

• To provide a comprehensive review of MAP types and their applications in vaccine delivery.
• To analyze MAP applications in both preclinical and clinical settings.
• To discuss considerations for microneedle-based vaccination, including adjuvants, safety, and global campaigns.

Main Methods:

• Literature review of preclinical and clinical studies on MAP vaccine delivery.
• Analysis of different MAP technologies and their immunogenicity.
• Examination of safety, adjuvant compatibility, and global vaccination factors.

Main Results:

• Clinical trials show safety, immunogenicity, and patient acceptance for MAP vaccines against influenza, measles, rubella, and SARS-CoV-2.
• MAPs have demonstrated effectiveness in various animal models for different pathogens.
• MAP vaccine delivery has the potential to significantly improve global vaccine distribution and coverage.

Conclusions:

• MAPs are a promising technology for vaccine delivery with demonstrated safety and efficacy.
• Overcoming hurdles like large-scale production and regulatory approval is crucial for widespread adoption.
• MAP-based vaccines may be available globally within the next five years, transforming public health initiatives.